Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPSTEIGLEMAN, Walter AllanROSE-NUSSBAUMER, JenniferAL-MOHTASEB, ZainaSANTHIAGO, Marcony R.LIN, Charlies C.PANTANELLI, Seth M.KIM, Stephen J.SCHALLHORN, Julie M.2024-04-052024-04-052023OPHTHALMOLOGY, v.130, n.1, p.87-98, 20230161-6420https://observatorio.fm.usp.br/handle/OPI/59107Objective: To evaluate current best practices for postoperative photorefractive keratectomy (PRK) pain control.Methods: Literature searches in the PubMed database were last conducted in October 2021 and were restricted to publications in English. This search identified 219 citations, of which 84 were reviewed in full text for their relevance to the scope of this assessment. Fifty-one articles met the criteria for inclusion; 16 studies were rated level I, 33 studies were rated level II, and 2 studies were rated level III.Results: Systemic opioid and nonsteroidal anti-inflammatory drugs (NSAIDs); topical NSAIDs; postoperative cold patches; bandage soft contact lenses (BCLs), notably senofilcon A contact lenses; and topical anesthetics were demonstrated to offer significantly better pain control than comparison treatments. Some other commonly reported pain mitigation interventions such as systemic gabapentinoids, chilled intraoperative balanced salt solution (BSS) irrigation, cycloplegia, and specific surface ablation technique strategies offered limited improvement in pain control over control treatments.Conclusions: Systemic NSAIDs and opioid medications, topical NSAIDs, cold patches, BCLs, and topical an-esthetics have been shown to provide improved pain control over alternative strategies and allow PRK-associated pain to be more tolerable for patients. Ophthalmology 2023;130:87-98 2022 by the American Academy of OphthalmologyengrestrictedAccessphotorefractive keratectomypain managementPKRbandage contact-lensesnonsteroidal antiinflammatory drugspreoperative topical diclofenaccodeine plus acetaminophenearly postoperative painepi-lasiksurface ablationvisual outcomesreducing painlotrafilcon barticleCopyright ELSEVIER SCIENCE INC10.1016/j.ophtha.2022.07.028Ophthalmology1549-4713